Cargando…
MAFLD: an optimal framework for understanding liver cancer phenotypes
Hepatocellular carcinoma has a substantial global mortality burden which is rising despite advancements in tackling the traditional viral risk factors. Metabolic (dysfunction) associated fatty liver disease (MAFLD) is the most prevalent liver disease, increasing in parallel with the epidemics of obe...
Autores principales: | Crane, Harry, Gofton, Cameron, Sharma, Ankur, George, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522746/ https://www.ncbi.nlm.nih.gov/pubmed/37470858 http://dx.doi.org/10.1007/s00535-023-02021-7 |
Ejemplares similares
-
MAFLD: How is it different from NAFLD?
por: Gofton, Cameron, et al.
Publicado: (2023) -
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
por: Kawaguchi, Takumi, et al.
Publicado: (2022) -
From MAFLD to hepatocellular carcinoma and everything in between
por: Bae, Sarah Da Won, et al.
Publicado: (2022) -
From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020) -
MAFLD and Celiac Disease in Children
por: Scapaticci, Serena, et al.
Publicado: (2023)